We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
+7.13%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$346M
AUM Growth
+$14.1M
Cap. Flow
-$6.22M
Cap. Flow %
-1.8%
Top 10 Hldgs %
35.85%
Holding
214
New
9
Increased
40
Reduced
123
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 17.07%
2 Healthcare 16.7%
3 Financials 12.6%
4 Industrials 9.31%
5 Communication Services 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
26
Arista Networks
ANET
$225B
$3.21M 0.93%
33,500
-5,600
-14% -$488K
NSC icon
27
Norfolk Southern
NSC
$75.4B
$2.93M 0.85%
11,777
-50
-0.4% -$12K
XOM icon
28
ExxonMobil
XOM
$637B
$2.79M 0.81%
23,806
+25
+0.1% +$2.89K
SBUX icon
29
Starbucks
SBUX
$120B
$2.73M 0.79%
28,027
+965
+4% +$82.8K
LIN icon
30
Linde
LIN
$221B
$2.61M 0.76%
5,481
-231
-4% -$105K
AMGN icon
31
Amgen
AMGN
$207B
$2.53M 0.73%
7,862
-106
-1% -$34.7K
META icon
32
Meta Platforms (Facebook)
META
$1.39T
$2.52M 0.73%
4,402
-104
-2% -$53.5K
VBR icon
33
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.49M 0.72%
12,401
-245
-2% -$47.1K
MGV icon
34
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.45M 0.71%
19,086
+3
+0% +$370
VIG icon
35
Vanguard Dividend Appreciation ETF
VIG
$111B
$2.36M 0.68%
11,901
-70
-0.6% -$13.3K
VCSH icon
36
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.33M 0.67%
29,285
-5,026
-15% -$394K
PG icon
37
Procter & Gamble
PG
$335B
$2.31M 0.67%
13,359
-205
-2% -$34.8K
CNC icon
38
Centene
CNC
$30.6B
$2.28M 0.66%
30,322
+290
+1% +$21.3K
DGX icon
39
Quest Diagnostics
DGX
$25.9B
$2.28M 0.66%
14,656
-100
-0.7% -$14.9K
UNP icon
40
Union Pacific
UNP
$174B
$2.26M 0.65%
9,161
-71
-0.8% -$17.2K
TECH icon
41
Bio-Techne
TECH
$11.2B
$2.07M 0.6%
25,920
-160
-0.6% -$12K
BDX icon
42
Becton Dickinson
BDX
$45.4B
$2.02M 0.58%
8,384
-5
-0.1% -$1.17K
VIGI icon
43
Vanguard International Dividend Appreciation ETF
VIGI
$9.07B
$1.94M 0.56%
22,032
-185
-0.8% -$15.7K
VRTX icon
44
Vertex Pharmaceuticals
VRTX
$120B
$1.93M 0.56%
4,155
-187
-4% -$89.8K
CVS icon
45
CVS Health
CVS
$134B
$1.92M 0.56%
30,563
-2,330
-7% -$136K
ADX icon
46
Adams Diversified Equity Fund
ADX
$3.1B
$1.9M 0.55%
87,917
+4,523
+5% +$96.2K
MTB icon
47
M&T Bank
MTB
$35.9B
$1.87M 0.54%
10,518
-945
-8% -$157K
VOO icon
48
Vanguard S&P 500 ETF
VOO
$973B
$1.84M 0.53%
3,482
-62
-2% -$31.5K
PYPL icon
49
PayPal
PYPL
$48.7B
$1.79M 0.52%
22,957
-3,134
-12% -$210K
MELI icon
50
Mercado Libre
MELI
$95.1B
$1.78M 0.51%
866
-77
-8% -$145K

Similar funds

Roberts, Glore & Co's Q3 2024 Portfolio in Review

As of Q3 2024, Roberts, Glore & Co held 214 positions worth $346M, up 4.3% from $332M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Roberts, Glore & Co's Q3 2024 filing shows 9 new, 40 increased, 123 reduced and 5 closed positions. Its largest new stake was Snowflake: 6,109 shares worth $702K. The largest sale was Atrion Corp, an estimated $2.27M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Roberts, Glore & Co's largest Q3 2024 buy was Snowflake: 6,109 shares worth $702K.
  • Roberts, Glore & Co added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2024, an estimated $807K increase.
  • Roberts, Glore & Co's biggest Q3 2024 reduction was Intel, cutting an estimated $931K.
  • Roberts, Glore & Co fully exited Atrion Corp in Q3 2024, selling an estimated $2.27M.
  • Roberts, Glore & Co's ten largest holdings make up 36% of its $346M portfolio in Q3 2024.
  • Roberts, Glore & Co opened 9 new positions and closed 5 in Q3 2024.
  • Roberts, Glore & Co's portfolio value rose 4.3% quarter-over-quarter to $346M.

Based on Roberts, Glore & Co's 13F filing for Q3 2024, filed 14 Nov 2024.